Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 10, 2015 - Issue
Submit an article Journal homepage
87
Views
8
CrossRef citations to date
0
Altmetric
Original Research

A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world

Yin Wan1 Health Economics and Modeling, Outcomes Research, Pharmerit International, Bethesda, MD, USA
,
Shawn X Sun2 Health Economics and Outcomes Research, Forest Laboratories, LLC, an affiliate of Actavis, Inc., Jersey City, NJ, USA
,
Shelby Corman1 Health Economics and Modeling, Outcomes Research, Pharmerit International, Bethesda, MD, USA
,
Xingyue Huang2 Health Economics and Outcomes Research, Forest Laboratories, LLC, an affiliate of Actavis, Inc., Jersey City, NJ, USA
,
Xin Gao1 Health Economics and Modeling, Outcomes Research, Pharmerit International, Bethesda, MD, USACorrespondence[email protected]
&
Andrew F Shorr3 Pulmonary Critical Care, Washington Hospital Center and Georgetown University, Washington, DC, USA
Pages 2127-2136 | Published online: 07 Oct 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Paola Rogliani, Luigino Calzetta, Mario Cazzola & Maria Gabriella Matera. (2016) Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis. Expert Opinion on Drug Safety 15:8, pages 1133-1146.
Read now
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2016) The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Discovery 11:7, pages 733-744.
Read now

Articles from other publishers (5)

Seokjin Ham, Yeon-Mok Oh & Tae-Young Roh. (2019) Evaluation and Interpretation of Transcriptome Data Underlying Heterogeneous Chronic Obstructive Pulmonary Disease. Genomics & Informatics 17:1, pages e2.
Crossref
Sangtaeck Lim, Gaurav Gangoli, Erica Adams, Robert Hyde, Michael S. Broder, Eunice Chang, Sheila R. Reddy, Marian H. Tarbox, Tanya Bentley, Liza Ovington & Walt DankerIIIIII. (2019) Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter–Related Complications: Analysis of a US Hospital Discharge Database. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 56, pages 004695801987556.
Crossref
V. Pauwelyn, W. Ceelen & R. A. Lefebvre. (2018) Synergy between 5-HT 4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle . Neurogastroenterology & Motility 30:2, pages e13162.
Crossref
David A. Johnson, David Lieberman, John M. Inadomi, Uri Ladabaum, Richard C. Becker, Seth A. Gross, Kristin L. Hood, Susan Kushins, Mark Pochapin & Douglas J. Robertson. (2017) Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Clinical Gastroenterology and Hepatology 15:6, pages 883-891.e9.
Crossref
Romain A. Lefebvre, Inge Van Colen, Vicky Pauwelyn & Joris H. De Maeyer. (2016) Synergistic effect between 5-HT4 receptor agonist and phosphodiesterase 4-inhibitor in releasing acetylcholine in pig gastric circular muscle in vitro. European Journal of Pharmacology 781, pages 76-82.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.